Clover Corporation Limited · ASX:CLV

Clover — H1 2017 Earnings Presentation

11 slides from Clover's earnings presentation, Mar 21, 2017

  1. Slide 1: Managing Director Report, 6 Months to 31 Jan 2017

    For personal use only Managing Director Report 6 Months to 31 Jan 2017 21 March 2017

  2. Slide 2: Vision and Mission Statement

    For personal use only Vision and Mission Statement Vision: To optimise the health and development of adults, infants and children. Mission: To deliver science based bioactives which provide health benefits to adults, infants, children and to the medical food markets. 1

  3. Slide 3: Half Year Performance Highlights

    For personal use only Half Year Performance Highlights $1.0m up  Net Profit  Interim fully franked 29.5% on half year 2016 dividend 0.25c declared  Operating Revenue  Inventory managed at $19.4m down 1.3% $13.8m similar to the on half year 2016 prior year  Operating expenses of  Balance sheet

  4. Slide 4: Half Year 2017 Results

    For personal use only Half Year 2017 Results AUD million 4D Reported 4D Reported • Year on year revenue flat 31 Jan 2017 31 Jan 2016 Revenue $19.44 $19.71 • Higher margin sales driven by customer mix and hedging USD Profit before $1.42 $1.08 invoices against purchases tax EBITDA $1.65 $1.26 • EBIT $

  5. Slide 5: Balance Sheet January 2017

    For personal use only Balance Sheet 31 January 2017 AUD million Reported Reported Movement 31 Jan 2017 31 Jul 2016 Cash $8.2 +$0.5 • Cash balance $8.7 strong $8.7m Trade $6.6 $10.9 -$4.3 Receivables • Inventories well Inventories $13.8 $13.6 +$0.2 managed Total Current $29.3 $33.1 -$3.8 Assets • Pay

  6. Slide 6: An Update on Growth Platforms

    For personal use only An Update on Growth Platforms Focus on infant formula customers and market New Driving Product, Market Process and relevant Market innovations Development 5

  7. Slide 7: Growth Platform: Focus on infant formula customers and market

    For personal use only Focus on Growth Platform infant formula customers Continued focus on the infant formula market and market  Focus on major Chinese players by employing a Chinese Business Development Manager with solid local networking and business acumen  New Chinese regulations requiring all

  8. Slide 8: Growth Platform: New Products, Process and Market Development

    New For personal use only Products, Growth Platform Process and Market Accelerating product development and launch Development  Expand global reach by developing specialised distribution networks to fast track new customer reach and commercialisation  Europe, USA and South East Asia  Functional f

  9. Slide 9: Growth Platform: Driving relevant innovations

    Driving For personal use only Growth Platform Market relevant innovations Strengthened Research & Development  Purchase and installation of lab-scale spray drying and analytical equipment to fast track new product development  Development of a novel emulsion delivery technology with application tr

  10. Slide 10: FY2017 Outlook & Priorities

    For personal use only FY2017 Outlook & Priorities • Leverage the removal of the one child policy and Chinese product formulation registration requirements to grow sales in the region • Develop input sources and production partnerships • Organic growth with emphasis on Oceania, Asia and Europe • Dive

  11. Slide 11: Disclaimer

    For personal use only Disclaimer The release, publication or distribution of this presentation in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this presentation is released, published or distributed should inform themselves about and observe s

Clover — H1 2017 Earnings Presentation on 6ix